Skip to main content

Table 2 Association between KLK8 and cognitive status (aMCI vs. CU)

From: Is kallikrein-8 a blood biomarker for detecting amnestic mild cognitive impairment? Results of the population-based Heinz Nixdorf Recall study

 

OR

95%CI

OR

95%CI

Per 500 pg/ml KLK8

1.113

0.821

1.511

2.683

1.053

6.835

Experimenter 2 vs. 3a

   

0.031

0.002

0.577

Experimenter 1 vs. 3a

   

5.916

0.897

39.033

Freezing duration, years

   

0.927

0.842

1.020

  1. Age and sex are taken into account by matching for them
  2. aMCI amnestic mild cognitive impairment, CU cognitive unimpaired, OR odds ratio, 95%CI 95%-confidence interval, KLK8 kallikrein 8
  3. a We adjusted for experimenter as a proxy for the inter-assay variability
Back to article page